Onward Therapeutics Finalizes Share Exchange, Sets Up Global HQ
11 Nov 2025 //
PR NEWSWIRE
Onward Signs Global License with ICM for Onco-Metabolism Program
27 Oct 2025 //
PR NEWSWIRE
Onward Therapeutics Announces IMPD Approval for NK Therapy
22 Apr 2025 //
PR NEWSWIRE

Market Place
Sourcing Support